Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for clarity.

Anticoagulants are medicines that help prevent the blood from clotting as normal. They treat and prevent blood clots. Examples of anticoagulants include: warfarin non-vitamin K antagonist oral ...

For patients requiring long-term anticoagulation, monotherapy with direct oral anticoagulants or vitamin K antagonists is recommended to minimize bleeding. Ongoing trials aim to clarify optimal ...

Current European atrial fibrillation (AF) guidelines have assigned a strong recommendation for the initiation of antithrombotic therapy to prevent thromboembolism in all but those AF patients at ...

The other (P-3) was a seventy-eight-year-old man with coronary-artery disease who was unusually resistant to the prothrombinopenic effects of coumarin anticoagulant drugs; this patient was ...

Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk ... “The PRESTIGE-AF trial is the first completed phase 3 trial of antithrombotic stroke prevention in ...

College of Biological Science and Engineering, Fuzhou University, Fujian, China PR (Y.Z., D.W., C.Y., Mingdong Huang, P.X.). College of Chemistry, Fuzhou University ...

[74] The results indicated that all of the novel anticoagulants were cost-effective alternatives, with apixaban 5 mg being the most cost-effective option (ICER US$15,026 per QALY) with 8.47 QALY.